The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran

Published:2017-06-09 Issue:7 Volume:15 Page:1317-1321
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Simon A.¹,Domanovits H.¹,Ay C.²^ORCID,Sengoelge G.³,Levy J. H.⁴,Spiel A. O.¹

Affiliation:

1. Department of Emergency Medicine Medical University of ViennaVienna Austria

2. Medical University of Vienna Clinical Division of Hematology and Hemostaseology Vienna Austria

3. Department of Nephrology and Dialysis Medical University of Vienna Vienna Austria

4. Department of Anesthesiology Duke University Durham NC USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.13706

Reference17 articles.

1. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

2. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

3. A specific antidote for dabigatran: functional and structural characterization

4. Idarucizumab for Dabigatran Reversal

5. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?;Thrombosis Research;2024-05

2. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding;European Journal of Anaesthesiology;2024-04-04

3. How the Hemostasis Laboratory can Help Clinicians to Manage Patients on Oral Anticoagulants;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

4. Update der Point-of-care-basierten Gerinnungstherapie;Die Anaesthesiologie;2024-01-23

5. Limitations of idarucizumab efficacy in acute renal failure - a case report;Klinická farmakologie a farmacie;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3